1
/
of
1
Elabscience
SKU:PKSH033975
Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc)
Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc)
Regular price
$162.00 USD
Regular price
Sale price
$162.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc), a cutting-edge biotechnological product designed to revolutionize the field of medical research and therapeutic applications. This meticulously engineered protein, derived from human sources, showcases exceptional potential in elucidating the intricate mechanisms underlying angiogenesis and lipid metabolism.
The Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc) is a fusion protein that combines the functional domains of Angiopoietin-related Protein 3 (ANGPTL3) with the Fc region of human immunoglobulin G (IgG). This fusion construct not only ensures enhanced stability and solubility but also facilitates efficient purification and subsequent downstream applications.
ANGPTL3, a member of the angiopoietin-like protein family, has garnered significant attention due to its pivotal role in regulating lipid metabolism and angiogenesis. By modulating the activity of lipoprotein lipase and endothelial lipase, ANGPTL3 exerts profound influence over lipid homeostasis, thereby influencing various physiological processes such as lipid absorption, transport, and storage. Furthermore, ANGPTL3 has been implicated in the regulation of glucose metabolism and insulin sensitivity, making it an intriguing target for therapeutic interventions in metabolic disorders.
The Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc) offers researchers and clinicians an invaluable tool to explore the intricate interplay between ANGPTL3 and lipid metabolism. Its high purity, bioactivity, and stability make it an ideal candidate for a wide range of applications, including in vitro studies, in vivo animal models, and drug development.
With its exceptional quality and reliability, the Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc) represents a significant advancement in the field of biotechnology. Unlock the potential of ANGPTL3 and unravel the mysteries of lipid metabolism with this groundbreaking product.
The Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc) is a fusion protein that combines the functional domains of Angiopoietin-related Protein 3 (ANGPTL3) with the Fc region of human immunoglobulin G (IgG). This fusion construct not only ensures enhanced stability and solubility but also facilitates efficient purification and subsequent downstream applications.
ANGPTL3, a member of the angiopoietin-like protein family, has garnered significant attention due to its pivotal role in regulating lipid metabolism and angiogenesis. By modulating the activity of lipoprotein lipase and endothelial lipase, ANGPTL3 exerts profound influence over lipid homeostasis, thereby influencing various physiological processes such as lipid absorption, transport, and storage. Furthermore, ANGPTL3 has been implicated in the regulation of glucose metabolism and insulin sensitivity, making it an intriguing target for therapeutic interventions in metabolic disorders.
The Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc) offers researchers and clinicians an invaluable tool to explore the intricate interplay between ANGPTL3 and lipid metabolism. Its high purity, bioactivity, and stability make it an ideal candidate for a wide range of applications, including in vitro studies, in vivo animal models, and drug development.
With its exceptional quality and reliability, the Recombinant Human Angiopoietin-related Protein 3/ANGPTL3 (C-Fc) represents a significant advancement in the field of biotechnology. Unlock the potential of ANGPTL3 and unravel the mysteries of lipid metabolism with this groundbreaking product.
Share
